Lysophosphatidylinositol causes neurite retraction via GPR55, G 13 and RhoA in PC12 cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Obara, Yutaro ^a   Ueno, Sanae ^a   Yanagihata, Yoshimi ^a   Nakahata, Norimichi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACTIN; CALCIUM ION; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LYSOPHOSPHATIDYLINOSITOL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; PHOSPHATIDYLINOSITOL; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CANNABINOID RECEPTOR; GPR55 PROTEIN, RAT; LYSOPHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL MEMBRANE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GROWTH CONE; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; GENETICS; METABOLISM; NEURITE;

ANIMALS; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; LYSOPHOSPHOLIPIDS; NEURITES; PC12 CELLS; RATS; RECEPTORS, CANNABINOID; RECEPTORS, G-PROTEIN-COUPLED; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 80052326134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024284     Document Type: Article

References (40)

1. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
2. Di Marzo V, Bifulco M, De Petrocellis L, (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3: 771-784.
3. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
4. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90.
5. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, et al. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215: 89-97.
6. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI, (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
7. Munro S, Thomas KL, Abu-Shaar M, (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
8. Pertwee RG, (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180.
9. Centonze D, Finazzi-Agro A, Bernardi G, Maccarrone M, (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 28: 180-187.
10. Brown AJ, (2007) Novel cannabinoid receptors. Br J Pharmacol 152: 567-575.
11. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, et al. (1999) Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64: 193-198.
12. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, et al. (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152: 1092-1101.
13. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, et al. (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 105: 2699-2704.
14. Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, et al. (2009) The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. Faseb J 23: 183-193.
15. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, et al. (2009) Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284: 29817-29827.
16. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T, (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362: 928-934.
17. Ross RA, (2009) The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30: 156-163.
18. Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, et al. (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106: 16511-16516.
19. Obara Y, Yamauchi A, Takehara S, Nemoto W, Takahashi M, et al. (2009) ERK5 Activity Is Required for Nerve Growth Factor-induced Neurite Outgrowth and Stabilization of Tyrosine Hydroxylase in PC12 Cells. J Biol Chem 284: 23564-23573.
20. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, et al. (2002) Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res 91: 961-969.
21. Honma S, Saika M, Ohkubo S, Kurose H, Nakahata N, (2006) Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. Eur J Pharmacol 545: 100-108.
22. Obara Y, Nakahata N, (2010) Novel method for the measurement of intracellular cAMP levels by using a fusion gene of PKA and firefly luciferase. Nippon Yakurigaku Zasshi 136: 285-289.
23. Binkowski B, Fan F, Wood K, (2009) Engineered luciferases for molecular sensing in living cells. Curr Opin Biotechnol 20: 14-18.
24. Fan F, Binkowski BF, Butler BL, Stecha PF, Lewis MK, et al. (2008) Novel genetically encoded biosensors using firefly luciferase. ACS Chem Biol 3: 346-351.
25. Fan F, Wood KV, (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5: 127-136.
26. Obara Y, Labudda K, Dillon TJ, Stork PJ, (2004) PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 117: 6085-6094.
27. Chiba T, Ueno S, Obara Y, Nakahata N, (2011) A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. J Pharm Pharmacol 63: 636-647.
28. Aoki K, Nakamura T, Matsuda M, (2004) Spatio-temporal regulation of Rac1 and Cdc42 activity during nerve growth factor-induced neurite outgrowth in PC12 cells. J Biol Chem 279: 713-719.
29. Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, et al. (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. J Biochem 145: 13-20.
30. Takasaki J, Saito T, Taniguchi M, Kawasaki T, Moritani Y, et al. (2004) A novel Galphaq/11-selective inhibitor. J Biol Chem 279: 47438-47445.
31. Yamashita A, Kumazawa T, Koga H, Suzuki N, Oka S, et al. (2010) Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): Possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1. Biochim Biophys Acta 1801: 711-720.
32. Pineiro R, Maffucci T, Falasca M, (2011) The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 30: 142-152.
33. Higgs HN, Han MH, Johnson GE, Glomset JA, (1998) Cloning of a phosphatidic acid-preferring phospholipase A1 from bovine testis. J Biol Chem 273: 5468-5477.
34. Yamazaki J, Katoh H, Negishi M, (2008) Lysophosphatidic acid and thrombin receptors require both G alpha12 and G alpha13 to regulate axonal morphology in hippocampal neurons. Biol Pharm Bull 31: 2216-2222.
35. Tigyi G, Fischer DJ, Sebok A, Yang C, Dyer DL, et al. (1996) Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho. J Neurochem 66: 537-548.
36. Nakamura T, Aoki K, Matsuda M, (2005) FRET imaging in nerve growth cones reveals a high level of RhoA activity within the peripheral domain. Brain Res Mol Brain Res 139: 277-287.
37. Cowley S, Paterson H, Kemp P, Marshall CJ, (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852.
38. Yamaguchi Y, Katoh H, Yasui H, Mori K, Negishi M, (2001) RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway. J Biol Chem 276: 18977-18983.
39. Metz SA, (1986) Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function. Biochem Biophys Res Commun 138: 720-727.
40. Ma MT, Yeo JF, Farooqui AA, Zhang J, Chen P, et al. (2010) Differential effects of lysophospholipids on exocytosis in rat PC12 cells. J Neural Transm 117: 301-308.